[Rating and ranking of medical journals: a randomised controlled evaluation of impact factor and number of listed journals]. / Rating und Ranking medizinischer Zeitschriften: Randomisiert kontrollierte Evaluation von Impact Factor und Zahl der gelisteten Journale.

BACKGROUND: The impact factor is a purely bibliometric parameter built on a number of publications and their citations that occur within clearly defined periods. Appropriate interpretation of the impact factor is important as it is also used worldwide for the evaluation of research performance. RESEARCH QUESTION: It is assumed that the number of medical journals reflects the extent of diseases and patient populations involved and that the number is correlated with the level of the impact factor. METHOD: 174 category lists (Subject Categories) are included in the area Health Sciences of the ISI Web of Knowledge of Thomson Reuters, 71 of which belong to the field of medicine and 50 of which have a clinical and/or application-oriented focus. These alphabetically arranged 50 category lists were consecutively numbered, randomized by odd and even numbers, respectively, into 2 equal-sized groups and then grouped according to organ specialities, sub-specialities and cross-disciplinary fields. By tossing up a coin it was decided which group should be evaluated first. Only then the category lists were downloaded and the number of journals, as well as the impact factors of journals ranking number 1 and 2, as well as the impact factors of journals at the end of the first third and at the end of the first half of each category list were compared. RESULTS: The number of journals per category list varies considerably between 5 and 252. The lists of organ specialties and cross-disciplinary fields include more than three times as many journals as those of the sub-specialities; the highest numbers of journals are listed for the cross-disciplinary fields. The level of impact factor of journals that rank number 1 in the lists varies considerably and ranges from 3,058 to 94,333; a similar variability exists for the journals at rank 2. On the other hand, the impact factor of journals at the end of the first third of the lists varies from 1,214 and 3,953, and for those journals at the end of the first half of a respective category list it varies from 0,609 and 2,872. The slope of the straight correlation line between the level of impact factors of journals at rank 1 and 2 with the number of listed journals varies from 0,0756 and 0,2651 (correlation coefficients between 0,49 and 0,96). For the journals ranking further down in the lists the straight correlation lines run almost horizontally or with inverse slope. CONCLUSIONS: This current analysis adds to the knowledge for an appropriate interpretation of the impact factor. Generally, greater importance should be given to the ranking of a journal within a corresponding category list.

The Crosstalk between Tumor Cells and the Microenvironment in Hepatocellular Carcinoma: The Role of Exosomal microRNAs and their Clinical Implications.

The communication between hepatocellular carcinoma (HCC) cells and their microenvironment is an essential mechanism supporting or preventing tumor development and progression. Recent evidence has identified extracellular vesicles (EVs) as one of the mechanisms mediating paracrine signaling between cells. Exosomes, the most described class of EVs, deliver proteins, mRNAs, noncoding RNAs, DNA, and lipids to recipient cells, also at remote distances. MicroRNAs (miRNAs), as part of the non-coding RNA exosomal cargo, have an important role in regulating cellular pathways in targeted cells, regulating several processes related to tumor progression invasion and metastasis, such as angiogenesis, immune-escape, epithelial-to-mesenchymal transition, invasion, and multi-drug resistance. Accumulating evidence suggests exosomal miRNAs as relevant players in the dynamic crosstalk among cancerous, immune, and stromal cells in establishing the tumorigenic microenvironment. In addition, they sustain the metastasic niche formation at distant sites. In this review, we summarized the recent findings on the role of the exosome-derived miRNAs in the cross-communication between tumor cells and different hepatic resident cells, with a focus on the molecular mechanisms responsible for the cell re-programming. In addition, we describe the clinical implication derived from the exosomal miRNA-driven immunomodulation to the current immunotherapy strategies and the molecular aspects influencing the resistance to therapeutic agents.